ABH Healthcare Limited (NSE:ABH)
India · Delayed Price · Currency is INR 80.70
-4.20 (-4.95%)
At close: Sep 4, 2026
ABH Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 56.45 | 53.39 | 16.56 | 7.12 | 0.85 |
Depreciation & Amortization | 23.68 | 20.86 | 17.25 | 15.41 | 0.71 |
Other Amortization | 0.18 | 0.18 | 0.18 | 0.18 | 0.01 |
Loss (Gain) From Sale of Assets | 1.18 | - | 7.43 | 0.19 | - |
Other Operating Activities | 46.24 | 51.18 | 24.01 | 9.03 | 0.55 |
Change in Accounts Receivable | -133.73 | -77.49 | -60.86 | -56.64 | -2.29 |
Change in Inventory | 12.08 | -15.67 | -6.32 | -2.5 | -20.09 |
Change in Accounts Payable | -1.82 | 10.86 | 6.62 | 8.83 | 40.27 |
Change in Other Net Operating Assets | 16.84 | -7.88 | 4.03 | 2.88 | 10.61 |
Operating Cash Flow | 21.11 | 35.44 | 8.88 | -15.5 | 30.63 |
Operating Cash Flow Growth | -40.45% | 299.08% | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -82.78 | -46.45 | -141.43 | -16.69 | -235.5 |
Sale of Property, Plant & Equipment | 5.34 | - | 12.01 | 2.16 | - |
Cash Acquisitions | - | 0.65 | - | - | - |
Investment in Securities | -14.57 | 0.37 | -1.21 | - | - |
Other Investing Activities | 0.58 | 0.09 | 0.01 | - | - |
Investing Cash Flow | -91.43 | -45.34 | -130.63 | -14.53 | -235.5 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 19.24 | 25.4 | 7.15 | 37.41 |
Long-Term Debt Issued | 187.75 | 30.73 | 122.69 | - | 168.82 |
Total Debt Issued | 187.75 | 49.96 | 148.09 | 7.15 | 206.22 |
Short-Term Debt Repaid | -56.17 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | -3.6 | - |
Total Debt Repaid | -56.17 | - | - | -3.6 | - |
Net Debt Issued (Repaid) | 131.58 | 49.96 | 148.09 | 3.54 | 206.22 |
Issuance of Common Stock | - | - | - | 38 | 1 |
Other Financing Activities | -37.1 | -34.12 | -27.7 | -12.16 | -0.19 |
Financing Cash Flow | 94.48 | 15.85 | 120.39 | 29.38 | 207.03 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 24.16 | 5.95 | -1.36 | -0.64 | 2.16 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -61.67 | -11.01 | -132.55 | -32.19 | -204.87 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -11.75% | -2.23% | -32.03% | -10.87% | -585.39% |
Free Cash Flow Per Share | -7.71 | -1.38 | -16.57 | -4.76 | -33.59 |
Levered Free Cash Flow | -136.4 | -62.03 | -173.81 | -48.25 | - |
Unlevered Free Cash Flow | -113.05 | -40.34 | -156.31 | -40.7 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 37.1 | 34.12 | 27.7 | 12.16 | 0.19 |
Cash Income Tax Paid | 14.39 | 6.07 | 11.19 | 8.59 | 0.02 |
Change in Working Capital | -106.62 | -90.17 | -56.54 | -47.43 | 28.51 |